Literature DB >> 2350443

Cerebrovascular disease in AIDS: a case-control study.

J R Berger1, J O Harris, J Gregorios, M Norenberg.   

Abstract

The autopsy records of adult patients dying with AIDS between 1983 and 1987 at a large, metropolitan, university-affiliated hospital were reviewed to determine the incidence and spectrum of cerebrovascular and associated cardiovascular disease. The clinical records of those patients with AIDS with cerebrovascular disease were retrospectively examined in detail. All autopsied patients between the ages of 20 and 50 years dying without AIDS in 1986 and 1987 served as the control group. At autopsy, 13 (8%) of 154 adult patients with AIDS had evidence of recent cerebrovascular disease. In comparison, 25 (23%) of the 111 control patients dying without AIDS had recent cerebrovascular disease (P less than 0.04). The spectrum of cerebrovascular diseases was similar in patients both with and without AIDS; however, cerebral vasculitis was observed only in the former. Thirty-nine (40%) of 97 patients with AIDS had significant cardiac disease, and cerebral emboli were demonstrated in four of the 13 patients with stroke. Stroke must be considered in the differential diagnosis of neurological disease in patients with AIDS, although it does not appear to be more common in this group than in a control population of young adults with other terminal illnesses. The causes of stroke occurring with AIDS are diverse and include cerebral emboli secondary to cardiac disease, cerebral hemorrhage secondary to thrombocytopenia, and cerebral vasculitis.

Entities:  

Mesh:

Year:  1990        PMID: 2350443     DOI: 10.1097/00002030-199003000-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

2.  Increased Cortical Cerebral Blood Flow in Asymptomatic Human Immunodeficiency Virus-Infected Subjects.

Authors:  Souvik Sen; Hongyu An; Prema Menezes; Jonathan Oakes; Joseph Eron; Weili Lin; Kevin Robertson; William Powers
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-05-05       Impact factor: 2.136

3.  Toward Understanding the When and Why of Human Immunodeficiency Virus-Associated Stroke.

Authors:  Bryan Smith
Journal:  J Infect Dis       Date:  2017-09-01       Impact factor: 5.226

4.  Neurosyphilis: MRI features and their phenotypic correlation in a cohort of 35 patients from a tertiary care university hospital.

Authors:  M Nagappa; S Sinha; A B Taly; S L Rao; S Nagarathna; P S Bindu; R D Bharath; P Murthy
Journal:  Neuroradiology       Date:  2012-12-30       Impact factor: 2.804

5.  Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men.

Authors:  Farrah J Mateen; Wendy S Post; Ned Sacktor; Alison G Abraham; James T Becker; Bryan R Smith; Roger Detels; Eileen Martin; John P Phair; Russell T Shinohara
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

Review 6.  Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

Authors:  Victor G Valcour; Cecilia M Shikuma; Michael R Watters; Ned C Sacktor
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

7.  HIV stroke risk: evidence and implications.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah L Commins; William Yong; Margrit Carlson
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

8.  Neuropathologic findings in AIDS and human immunodeficiency virus infection--report on 30 patients.

Authors:  E Kay; J J Dinn; M A Farrell
Journal:  Ir J Med Sci       Date:  1991-12       Impact factor: 1.568

9.  Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.

Authors:  Isabel M Elicer; Desiree Byrd; Uraina S Clark; Susan Morgello; Jessica Robinson-Papp
Journal:  J Neurovirol       Date:  2018-04-25       Impact factor: 2.643

10.  Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system.

Authors:  Felicia C Chow; Susan Regan; Steven Feske; James B Meigs; Steven K Grinspoon; Virginia A Triant
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.